Cathepsin D immobilized capillary reactors for on‐flow screening assays

[1]  R. Moaddel,et al.  Comparison of analytical techniques for the identification of bioactive compounds from natural products. , 2016, Natural product reports.

[2]  C. L. Cardoso,et al.  Label-free offline versus online activity methods for nucleoside diphosphate kinase b using high performance liquid chromatography. , 2016, The Analyst.

[3]  G. Oliva,et al.  Isolation of Tiliroside from Spiranthera odoratissima as Inhibitor of Trypanosoma cruzi Glyceraldehyde-3-phosphate Dehydrogenase by Using Bioactivity-Guided Fractionation , 2016 .

[4]  D. Santos,et al.  Characterization and screening of tight binding inhibitors of xanthine oxidase: An on-flow assay , 2015 .

[5]  J. Fernandes,et al.  New approach for natural products screening by real-time monitoring of hemoglobin hydrolysis using quartz crystal microbalance. , 2015, Analytica chimica acta.

[6]  A. Harvey,et al.  The re-emergence of natural products for drug discovery in the genomics era , 2015, Nature Reviews Drug Discovery.

[7]  M. Cooper,et al.  Natural product and natural product derived drugs in clinical trials. , 2014, Natural product reports.

[8]  Douglas S. Auld,et al.  Considerations for the design and reporting of enzyme assays in high-throughput screening applications , 2014 .

[9]  G. Massolini,et al.  Evaluation of capillary chromatographic supports for immobilized human purine nucleoside phosphorylase in frontal affinity chromatography studies. , 2014, Journal of chromatography. A.

[10]  Q. Cass,et al.  Corrigendum to "New trends in LC protein ligand screening" (J. Pharmaceut. Biomed. Anal. 87 (2014) 155-156) , 2014 .

[11]  David J Newman,et al.  Natural products: a continuing source of novel drug leads. , 2013, Biochimica et biophysica acta.

[12]  L. Vieira,et al.  Acetylcholinesterase immobilized capillary reactors-tandem mass spectrometry: an on-flow tool for ligand screening. , 2013, Journal of medicinal chemistry.

[13]  Robert A. Copeland,et al.  Evaluation of enzyme inhibitors in drug discovery , 2013 .

[14]  L. A. Basso,et al.  Capillary bioreactors based on human purine nucleoside phosphorylase: a new approach for ligands identification and characterization. , 2012, Journal of Chromatography A.

[15]  Martin Fusek,et al.  Cathepsin D--many functions of one aspartic protease. , 2008, Critical reviews in oncology/hematology.

[16]  R. Moaddel,et al.  Conformational mobility of immobilized proteins. , 2007, Journal of pharmaceutical and biomedical analysis.

[17]  V. Laurent-Matha,et al.  Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. , 2006, Cancer letters.

[18]  G. Oliva,et al.  Development and characterization of an immobilized enzyme reactor (IMER) based on human glyceraldehyde-3-phosphate dehydrogenase for on-line enzymatic studies. , 2006, Journal of chromatography. A.

[19]  William Ng,et al.  Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 2. Identification of small-molecule inhibitors via coupling with virtual screening. , 2005, Journal of medicinal chemistry.

[20]  Pavel Majer,et al.  Homology modeling and SAR analysis of Schistosoma japonicum cathepsin D (SjCD) with statin inhibitors identify a unique active site steric barrier with potential for the design of specific inhibitors , 2005, Biological chemistry.

[21]  Jin-Rui Dai,et al.  Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 1. Comparison with conventional ELISA. , 2004, Journal of medicinal chemistry.

[22]  Randy Hoffman,et al.  Overcoming compound interference in fluorescence polarization-based kinase assays using far-red tracers. , 2004, Assay and drug development technologies.

[23]  Vincenza Andrisano,et al.  Development and characterization of an immobilized enzyme reactor based on glyceraldehyde-3-phosphate dehydrogenase for on-line enzymatic studies. , 2003, Journal of chromatography. A.

[24]  D. Fairlie,et al.  Proteolysis of human hemoglobin by schistosome cathepsin D. , 2001, Molecular and biochemical parasitology.

[25]  H. Rochefort,et al.  Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[26]  D. Fairlie,et al.  Protease inhibitors: current status and future prospects. , 2000, Journal of medicinal chemistry.

[27]  A. Akamine,et al.  Characterization of new fluorogenic substrates for the rapid and sensitive assay of cathepsin E and cathepsin D. , 1999, Journal of biochemistry.

[28]  D. S. Hage,et al.  Recent advances in chromatographic and electrophoretic methods for the study of drug-protein interactions. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[29]  J. Collins,et al.  Design of sensitive fluorogenic substrates for human cathepsin D , 1997, FEBS letters.

[30]  H. Hamazaki.  Cathepsin D is involved in the clearance of Alzheimer's β‐amyloid protein , 1996 .

[31]  H. Hamazaki.  Cathepsin D is involved in the clearance of Alzheimer's beta-amyloid protein. , 1996, FEBS letters.

[32]  P. Brodelius.  Enzyme assays. , 1991, Current opinion in biotechnology.

[33]  D. Rich,et al.  An improved cathepsin-D substrate and assay procedure. , 1983, Analytical biochemistry.